04272017Headline:

New York, New York

HomeNew YorkNew York

Kendra Goldhirsch

Texas Man Blames Eliquis for His Wife’s Death

A Texas man filed a new lawsuit against Bristol-Myers Squibb and Pfizer, Inc., manufacturers of the blood-thinning drug Eliquis. He filed as Personal Representative of his wife’s Estate, whom he claims passed away as a result of taking Eliquis. The […]

Roopal Luhana

FDA Announces Mylan’s Recall of EpiPen Auto-Injectors Shortly After Class Action Filed

The FDA has announced Mylan’s expanded recall of select lots of its EpiPen Auto-Injector and EpiPen Jr. Auto-Injector. This follows the original recall that the company announced in March 2017. Initially, they recalled units sold only in Australia, due to […]

Kendra Goldhirsch

Nevada Woman Files Zostavax Lawsuit After Suffering Eye Problems

If you’re over the age of 60, you’ve probably been told that it’s time to start thinking about the shingles vaccine, Zostavax. This vaccine is intended to help reduce the risk of shingles. For those who develop the condition despite […]

Kendra Goldhirsch

FDA Warns Patients Without a Gallbladder to Beware Viberzi

According to the FDA, if you have gone through a surgical procedure to remove your gallbladder, you shouldn’t be using Viberzi (eluxadoline), a prescription drug treatment for irritable bowel syndrome (IBS). In a recent drug safety communication, the FDA warned […]

Roopal Luhana

AbbVie Seeks to Dismiss Plaintiffs’ Expert Testimony in Testosterone Litigation

Testosterone replacement manufacturer AbbVie wants to dismiss testimony from plaintiffs’ experts in consolidated testosterone litigation. In a motion filed on February 20, 2017, the defendants requested that U.S. District Judge Matthew F. Kennelly, who is overseeing centralized proceedings in the […]

Roopal Luhana

New Testosterone Studies: One Shows Increase of Plaque Build-Up

For the last few years, testosterone replacement drug manufacturers have been defending thousands of lawsuits filed by plaintiffs who took the drugs and then suffered from cardiovascular and venous thromboembolic events. Meanwhile, study results on the risks and benefits associated […]

Kendra Goldhirsch

Xarelto Manufacturers Eye New Patient Population as Lawsuits Continue

The anticoagulant drug Xarelto (rivaroxaban) is currently the subject of over 15,000 personal injury lawsuits pending in the Eastern District of Louisiana in a consolidated MDL litigation. Plaintiffs in these suits allege that after taking the drug, they suffered excessive […]

Roopal Luhana

FDA Drafts Guidelines on Off-Label Prescription Drug Marketing

Plaintiffs who file personal injury lawsuits against prescription drug manufacturers typically assert failure to warn claims, which provide that the drug makers failed to provide adequate warnings about the risks associated with their products. Instead, they argue that the manufacturers […]

Kendra Goldhirsch

JPML Consolidates Eliquis Litigation in New York

In October 2016, Eliquis manufacturers Bristol-Meyers Squibb and Pfizer Inc. submitted a petition to the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all Eliquis lawsuits into one court for pre-trial proceedings. They argued at the time that coordination […]

Roopal Luhana

Judge Fallon Sets New Dates for Xarelto Bellwether Trials

According to a recent Case Management Order entered in the Xarelto Multidistrict Litigation in federal court (Xarelto MDL), the first Xarelto bellwether trials have been delayed. The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits […]